ArticleIEEE transactions on medical imaging2026
Text-Driven Tumor Synthesis.
Article in IEEE transactions on medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Metadata-Guided Limited-Angle CT Image Reconstruction.IEEE transactions on medical imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Tumor synthesis can generate challenging cases that AI often misses or over-detects. Training on these cases improves AI performance. However, most existing synthesis methods are either unconditional- generating images from random variables-or conditioned only on tumor shape. As a result, they lack control over clinically important tumor characteristics, such as texture, heterogeneity, boundary, and pathology. The generated tumors are therefore overly similar or duplicates of existing training cases, failing to effectively address AI's weaknesses. We propose a new text-driven tumor synthesis approach, termed TextoMorph, that provides textual control over tumor characteristics in conjunction with mask control. This approach is particularly beneficial for examples that confuse the AI the most, such as early tumor detection (improving Sensitivity by + 6.5%), tumor segmentation for precise radiotherapy (improving NSD by + 3.1%), and classification between benign and malignant tumors (improving Sensitivity by + 8.2%). By incorporating text mined from radiology reports into the synthesis process, we increase the variability and controllability of the synthetic tumors to target AI's failure cases more precisely. Moreover, TextoMorph uses contrastive learning across different texts and CT scans, significantly reducing dependence on scarce image-report pairs (only 141 pairs used in this study) by leveraging a large corpus of 34,035 radiology reports. Finally, we have developed rigorous tests to evaluate synthetic tumors, showing that our synthetic tumors is realistic and diverse in texture, heterogeneity, boundary, and pathology. Code and models are available at https://github.com/MrGiovanni/TextoMorph.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.